Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
Publications
Publications
  • January 2014
  • Supplement
  • HBS Case Collection

Amgen Inc.: Pursuing Innovation and Imitation? (B)

By: Ian Mackenzie
  • Format:Print
  • | Language:English
  • | Pages:4
ShareBar

Abstract

The (B) case reveals that Sharer decided that Amgen should enter the emerging biosimilars business. However, he took the better part of a year to syndicate the decision across the senior team while in parallel investing in some time-critical process development. The (B) case then focuses on how the new business should be implemented, particularly in terms of integration versus separation of a new business unit, choice of unit leader, and whether Amgen should partner with a third party to gain access to skills or resources.

Keywords

Corporate Strategy; Pharmaceutical Industry; Biotechnology Industry; United States

Citation

Mackenzie, Ian. "Amgen Inc.: Pursuing Innovation and Imitation? (B)." Harvard Business School Supplement 714-426, January 2014.
  • Purchase

Related Work

    • January 2014 (Revised June 2015)
    • Faculty Research

    Amgen Inc: Pursuing Innovation and Imitation? (A), (B)

    By: Ian Mackenzie
Related Work
  • Amgen Inc: Pursuing Innovation and Imitation? (A), (B) By: Ian Mackenzie
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.